-
Innovative TCM Qinwei Granules approved for marketing
2024-03-23
The Category 1.1 innovative traditional Chinese medicine (TCM) Qinwei Granules of Chengdu Huaxi Natural Medicine Co Ltd was recently approved for marketing by the National Medical Products Administration.
-
Numbers report China's progress in medical and healthcare sector
2024-03-05
China's medical and healthcare sector witnessed sound progress last year, with the major health indicators reaching the forefront among middle- and high-income countries, according to data released by the National Health Commission.
-
Innovative TCM Jiuwei cough syrup approved for marketing
2024-02-27
Recently, the Category 1.1 innovative traditional Chinese medicine (TCM) Jiuwei Zhike Koufuye (cough syrup) of Zhuohe Pharmaceutical Group Co Ltd was approved for marketing by China's National Medical Products Administration.
-
Promulgation of the Rules for the Application of Discretion in Imposing Administrative Penalties in the Supervision and Administration of Medicinal Products
2024-02-23
Recently, the Rules for the Application of Discretion in Imposing Administrative Penalties in the Supervision and Administration of Medicinal Products were issued by China NMPA, which will come into force from August 1, 2024 onwards.
-
Innovative TCM Jiuwei Cough Syrup Approved for Marketing by China NMPA
2024-02-21
Recently, the Category 1.1 innovative traditional Chinese medicine (TCM) Jiuwei Zhike Koufuye (cough syrup) of Zhuohe Pharmaceutical Group Co Ltd was approved for marketing by China NMPA.
-
China to establish organization for poliovirus containment
2024-02-21
China will establish an organization to better fulfill its commitment to global polio eradication efforts and reduce biosecurity risks, according to the National Health Commission.
